Although Dex treatment caused significantly severe colitis, mTOR signaling deficiency in myeloid cells did not significantly alter the course of DSS-induced colitis, including weight loss, changes in colon length, pathological damage, inflammatory immune cell infiltration and the production of the inflammatory cytokines TNFα and IL-6 (Figure 6a–f). Here, IL6 is linked to colitis.